일중 데이터의 기간을 직접 선택하세요. 내보내기에는 2~3분이 걸릴 수 있습니다. 이 탭을 열어두시면 다운로드가 자동으로 시작됩니다.
데이터 없음
A detailed description of the company is not yet available....
Eurofins Scientific (ENXTPA:ERF) has drawn fresh attention after completing a share buyback program totalling 7,029,661 shares, or 3.97% of its capital, for €414.45 million announced in April 2025. Se...
Eurofins Scientific stock has delivered a decline of 28.9% over the past 5 years, yet a Discounted Cash Flow (DCF) intrinsic value estimate currently points to the shares trading at a 47.7% discount t...
Eurofins Scientific SE (ERFSF) reports a robust 29% EPS growth and significant margin improvements, despite facing FX headwinds and challenges in the biopharma sector.
Eurofins Scientific (ENXTPA:ERF) has caught investor attention after a recent move in the share price, combining a modest daily slip with stronger gains over the past week, month, and past 3 months. S...
Recent share performance and business snapshot Eurofins Scientific (ENXTPA:ERF) has drawn attention after recent share price moves, including a gain of about 1.3% over the past day and a decline of ro...